Teladoc Health (TDOC) Q1 2026 earnings review

Top Line Stagnates as BetterHelp Margins Evaporate

Teladoc's Q1 2026 results confirm a painful transition period. Consolidated revenue fell 2% to $613.8M, weighed down by a 9% contraction in BetterHelp. The direct-to-consumer (DTC) cash-pay model is deteriorating rapidly, forcing management into an expensive pivot toward insurance-covered therapy. This shift crushed BetterHelp's Adjusted EBITDA margin, which plummeted to just 0.9% (down from 3.2% a year ago). While Integrated Care provided a modest 2% growth buffer, Q2 guidance indicates total revenue will continue decelerating. Teladoc is trading near-term profitability for long-term survival, but the turnaround is not yet visible in the numbers.

๐Ÿ‚ Bull Case

International Growth Accelerating

Non-U.S. revenue jumped 17% YoY to $122.3M, outpacing the 12% growth seen in early 2025. This provides a durable growth flanker while the domestic business undergoes reconstruction.

Disciplined Cost Control

Despite margin pressure in BetterHelp, consolidated Adjusted EBITDA remained stable at $58.2M. Stock-based compensation was slashed to $14.6M from $25.2M a year ago, reflecting serious operational discipline.

๐Ÿป Bear Case

BetterHelp Profitability Collapse

BetterHelp's Adjusted EBITDA margin dropped to 0.9% and Q2 guidance implies it could hit negative territory (-0.5% at the low end). The transition from cash-pay to insurance is destroying segment economics.

Integrated Care Stalling

Despite touting an AI-enhanced platform, Integrated Care revenue guidance for Q2 is essentially 0% growth at the midpoint (-1.75% to +1.75%), exposing a lack of core pricing power.

โš–๏ธ Verdict: ๐Ÿ”ด

Bearish. The core cash-pay consumer business is shrinking, and the cost of pivoting to a B2B/insurance model is vaporizing BetterHelp's margins. With no near-term catalyst for top-line re-acceleration, the stock remains a 'show me' story.

Key Themes

CONCERN๐Ÿ”ด๐Ÿ”ด

BetterHelp Margin Compression

BetterHelp's Adjusted EBITDA margin crashed from 3.2% in 25Q1 to 0.9% in 26Q1. This decelerating profitability trajectory is alarming. The segment is bleeding higher-margin cash-pay users while front-loading investments to credential providers and build an insurance billing infrastructure. Q2 guidance projects a midpoint margin of just 0.5%, signaling that the profitability trough has not yet been reached.

DRIVERโšช

The Insurance Pivot is Essential but Painful

Faced with a 9% YoY drop in BetterHelp paying users (down to 361K), management is aggressively transitioning the segment from an ad-driven cash-pay model to an in-network insurance offering. While the investments are temporarily crushing margins, integrating with over 120M covered lives is the only viable path to stabilize the top of the funnel and improve conversion rates over the long term.

CONCERN๐Ÿ”ด

Empty Calorie Membership Growth in Integrated Care

Management frequently highlights Integrated Care's massive scale, which reached 101.2M members. However, the data contradicts the cross-sell narrative. Despite high membership levels, Average Monthly Revenue Per U.S. Member was just $1.30, virtually flat YoY and notably lower than the $1.38 seen in 24Q1. The company is failing to effectively cross-sell higher-margin Chronic Care products to its vast, lower-tier member base.

DRIVER๐ŸŸข

International Flanker Continues to Deliver

While the U.S. market contracts (down 6% YoY), International revenue is accelerating. Segment revenue grew 17% YoY to $122.3M, outpacing the 10-12% growth rates seen through most of 2025. This geographical diversification provides much-needed stable cash flow to fund domestic turnarounds.

DRIVER๐ŸŸข

AI Platform ('Pulse') Integration

To defend Integrated Care renewals against heavy competition, Teladoc is leaning into product innovation. The rollout of the 'Pulse' data/AI platform for ambient clinical documentation and the 'Clarity' computer vision tool for hospital patient safety represent a critical shift from generic telemedicine to high-value workflow software.

CONCERN๐Ÿ”ด

Macro Weakness Pressures Churn

Management continues to cite macroeconomic uncertainty and weak consumer sentiment as the primary catalysts for churn in BetterHelp's DTC channel. As inflation and tight household budgets persist, out-of-pocket virtual therapy is increasingly treated as discretionary spending, amplifying the urgency of the insurance rollout.

Other KPIs

Free Cash Flow (26Q1)Outflow of $26.3 million

Reversing the slight improvements seen late last year, FCF burned deeper compared to the $15.7M outflow in 25Q1. This was driven by a negative $9.5M in operating cash flow (down from $15.9M) combined with elevated Capital Expenditures and software development costs of $35.8M. The working capital drain highlights the operational friction of their business model transitions.

Stock-Based Compensation (26Q1)$14.6 million

A notable bright spot. SBC was slashed by 42% YoY from $25.2 million. This demonstrates management's commitment to halting excessive shareholder dilution and rightsizing the cost structure amidst top-line stagnation.

Guidance

26Q2 Consolidated Revenue$597 - $626 million

Decelerating. The $611.5M midpoint implies a ~3.2% YoY decline, which is worse than the 2% decline printed in 26Q1. The top-line bleeding is expected to accelerate slightly into the summer.

26Q2 BetterHelp Revenue Growth(11.75%) to (5.25%) YoY

Stable to slightly Decelerating. The -8.5% midpoint essentially mirrors Q1's -9% print, indicating that the new insurance revenues are not yet large enough to offset the structural decay of the core cash-pay subscriber base.

26Q2 Integrated Care Revenue Growth(1.75%) to 1.75% YoY

Decelerating. Dropping from +2% in Q1 to a flat 0% at the midpoint. This indicates serious pricing pushback and client churn in the B2B market, stripping away the company's only remaining growth engine.

FY26 Adjusted EBITDA$267 - $306 million

Stable. The $286.5M midpoint is roughly flat against 2025 actuals. Management expects steep back-half margin improvement (primarily Q4 seasonality) to compensate for the heavily depressed Q1 and Q2 margins.

Key Questions

BetterHelp Margin Floor

With Q2 BetterHelp Adjusted EBITDA guidance dipping dangerously close to 0%, at what point in the year do you expect the margin compression from the insurance rollout to bottom out?

Integrated Care Deceleration

Q2 guidance implies Integrated Care revenue growth will stall completely. Is this driven by membership losses, PMPM pricing pressure, or lower visit utilization?

Insurance Conversion Metrics

As the UpLift infrastructure scales, what percentage of the BetterHelp top-of-funnel traffic is successfully matching with their in-network benefits, and how does their session retention compare to legacy cash-pay users?